2011

• Ho, P., Tay, L., Lindeman, R., Catley, L., Bowden, D. (2011), Australian Guidelines for the assessment of iron overload and iron chelation in transfusion-dependent thalassaemia major, sickle cell disease and other congenital anaemias. Internal medicine journal. 41(7), 516-24. [Abstract]
• Viprakasit, V., Ibrahim, H., Ha, S., Ho, P., Li, C., Chan, L., Chiu, C., Sutcharitchan, P., Habr, D., Domokos, G., Roubert, B., Xue, H., Bowden, D., Lin, K. (2011), Clinical efficacy and safety evaluation of tailoring iron chelation practice in thalassaemia patients from Asia-Pacific: a subanalysis of the EPIC study of deferasirox. International Journal of Hematology. 93(3), 319-328. [Abstract]

2010

• Perera, N., Lau, N., Mathews, S., Waite, C., Ho, P., Caterson, I. (2010), Overview of endocrinopathies associated with β-thalassaemia major. Internal Medicine Journal. 40(10), 689-696. [Abstract]
• Li, J., Sze, D., Brown, R., Cowley, M., Kaplan, W., Mo, S., Yang, S., Aklilu, E., Kabani, K., Loh, Y., Yamagishi, T., Chen, Y., Ho, P., Joshua, D. (2010), Clonal expansions of cytotoxic T cells exist in the blood of patients with Waldenstrom's Macroglobulinaemia but exhibit anergic properties and are eliminated by nucleoside analogue therapy. Blood. 115(17), 3580-8. [Abstract]

2009

• Brown, R., Spencer, A., Ho, P., Kennedy, N., Kabani, K., Yang, S., Sze, D., Aklilu, E., Gibson, J., Joshua, D. (2009), Prognostically significant cytotoxic T cell clones are stimulated after thalidomide therapy in patients with multiple myeloma. Leukemia and Lymphoma. 50(11), 1860-1864. [Abstract]

2008

• Joshua, D., Brown, R., Ho, P., Gibson, J. (2008), Regulatory T cells and Multiple Myeloma. Clinical Lymphoma & Myeloma. 8(5), 283-286. [Abstract]

2007

• Sanders, J., Crawford, B., Gibson, J., Joy Ho, P., Iland, H., Joshua, D. (2007), Is there a case for the early use of bisphosphonates in smouldering myeloma and MGUS? (Bisphosphonates in SMM & MGUS). International journal of laboratory hematology. , 395-397. [Abstract]
• Ling, S., Campbell, L., Ho, J., Gibson, J., Joshua, D. (2007), Molecular Biology, Pathology, and Cytogenetics. In: Clinical Malignant Haematology. (pp.847-857).United States: McGraw Hill.
• Osborne, R., De Abreu Lourenço, R., Dalton, A., Houltram, J., Dowton, D., Joshua, D., Lindeman, R., Ho, P. (2007), Quality of life related to oral versus subcutaneous iron chelation: a time trade-off study. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 10(6), 451-456. [Abstract]

2006

• Sze, D., Brown, R., Yang, S., Ho, P., Gibson, J., Joshua, D. (2006), The use of thalidomide in myeloma therapy as an effective anticancer drug. Current cancer drug targets. 6(4), 325-31. [Abstract]
• Ling, S., Joshua, D., Gibson, J., Young, G., Iland, H., Watson, G., Ho, P. (2006), Transformation and progression of Waldenström's macroglobulinemia following cladribine therapy in two cases: natural evolution or iatrogenic causation?. American journal of hematology. 81(2), 110-4. [Abstract]
• Trent, R., Webster, B., Bowden, D., Gilbert, A., Ho, P., Lindeman, R., Lammi, A., Rowell, J., Hinchcliffe, M., Colley, A., Wilson, M., Saleh, M., Blackwell, J., Vicki, P. (2006), Complex phenotypes in the haemoglobinopathies: recommendations on screening and DNA testing. Pathology. 38(6), 507-519.